<DOC>
	<DOCNO>NCT02507128</DOCNO>
	<brief_summary>The investigator plan evaluate effect liraglutide no-reflow patient acute ST-segment elevation myocardial infarction ( STEMI ) .</brief_summary>
	<brief_title>Effects Glucagon Like Peptide-1 No-reflow</brief_title>
	<detailed_description>Acute myocardial infarction ( AMI ) major cause mortality morbidity . Primary percutaneous coronary intervention ( PCI ) currently effective treatment strategy AMI . Brisk thrombolysis myocardial infarction ( TIMI ) grade 3 flow immediately PCI patient AMI associate improved clinical outcome compare low flow grade . However , myocardial reperfusion suboptimal many patient , mostly 'no-reflow ' phenomenon . No-reflow defined suboptimal myocardial reperfusion part coronary circulation without angiographic evidence mechanical vessel obstruction . To date , however , drug show reverse establish no-reflow . Glucagon-like peptide-1 ( GLP-1 ) incretin hormone regulate plasma glucose , GLP-1 analogues recently introduce treatment acute myocardial infarction . GLP-1 antioxidant anti-inflammatory property , may protect endothelial function . Experimental study also reveal GLP-1 analogue protect reperfusion injury pig . Exenatide , GLP-1 analogue , report reduce reperfusion injury patient ST-segment elevation myocardial infarction . Similarly , liraglutide report reduce cardiac rupture infarct size improve cardiac output normal diabetic mouse . To date , however , clinical evidence effect liraglutide no-reflow patient AMI . Therefore , aim study evaluate effect liraglutide pretreatment myocardial no-reflow prime PCI patient AMI .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Glucagon</mesh_term>
	<mesh_term>Glucagon-Like Peptide 1</mesh_term>
	<mesh_term>Liraglutide</mesh_term>
	<criteria>Patients STsegment elevation myocardial infarction eligible study . Patients exclude follow reason : unconscious presentation ; cardiogenic shock , hypoglycaemia , diabetic ketoacidosis ; history myocardial infarction , stent thrombosis , renal insufficiency ; previously undergone coronary artery bypass surgery .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>